Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Page

Showing results (261-270 of 265) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 265 results.
Journal of Medicinal Chemistry|August 10, 2018
A Fragment-Derived Clinical Candidate for Antagonism of X-Linked and Cellular Inhibitor of Apoptosis Proteins: 1-(6-[(4-Fluorophenyl)methyl]-5-(hydroxymethyl)-3,3-dimethyl-1 H,2 H,3 H-pyrrolo[3,2- b]pyridin-1-yl)-2-[(2 R,5 R)-5-methyl-2-([(3R)-3-methylmorpholin-4-yl]methyl)piperazin-1-yl]ethan-1-one (ASTX660)Christopher N Johnson, Jong Sook Ahn, Ildiko M Buck, et al.
Applied and Environmental Microbiology|May 27, 2026
Mars sample return campaign: biological risk and a proposed sample safety assessment protocolG McDonnell, B L Teece, R Mackelprang, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2009
Identification of [4-[4-(methylsulfonyl)phenyl]-6-(trifluoromethyl)-2-pyrimidinyl] amines and ethers as potent and selective cyclooxygenase-2 inhibitorsMartin E Swarbrick, Paul J Beswick, Robert J Gleave, et al.
Journal of Medicinal Chemistry|May 12, 2016
Exploitation of a Novel Binding Pocket in Human Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Discovered through X-ray Fragment ScreeningAlison J-A Woolford, Joseph E Pero, Sridhar Aravapalli, et al.
Environmental Health Perspectives|December 23, 2006
Workgroup report: public health strategies for reducing aflatoxin exposure in developing countriesHeather Strosnider, Eduardo Azziz-Baumgartner, Marianne Banziger, et al.
Pageof 27

Showing results (261-270 of 265) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 265 results.
Journal of Medicinal Chemistry|August 10, 2018
A Fragment-Derived Clinical Candidate for Antagonism of X-Linked and Cellular Inhibitor of Apoptosis Proteins: 1-(6-[(4-Fluorophenyl)methyl]-5-(hydroxymethyl)-3,3-dimethyl-1 H,2 H,3 H-pyrrolo[3,2- b]pyridin-1-yl)-2-[(2 R,5 R)-5-methyl-2-([(3R)-3-methylmorpholin-4-yl]methyl)piperazin-1-yl]ethan-1-one (ASTX660)Christopher N Johnson, Jong Sook Ahn, Ildiko M Buck, et al.
Applied and Environmental Microbiology|May 27, 2026
Mars sample return campaign: biological risk and a proposed sample safety assessment protocolG McDonnell, B L Teece, R Mackelprang, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2009
Identification of [4-[4-(methylsulfonyl)phenyl]-6-(trifluoromethyl)-2-pyrimidinyl] amines and ethers as potent and selective cyclooxygenase-2 inhibitorsMartin E Swarbrick, Paul J Beswick, Robert J Gleave, et al.
Journal of Medicinal Chemistry|May 12, 2016
Exploitation of a Novel Binding Pocket in Human Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Discovered through X-ray Fragment ScreeningAlison J-A Woolford, Joseph E Pero, Sridhar Aravapalli, et al.
Environmental Health Perspectives|December 23, 2006
Workgroup report: public health strategies for reducing aflatoxin exposure in developing countriesHeather Strosnider, Eduardo Azziz-Baumgartner, Marianne Banziger, et al.
Pageof 27